NRP1 and NRP2 have already been implicated in cancer invasion, metastasis and progression [16, 64–68], but this is not the case for SEMA3F, which has been traditionally considered a good prognostic marker not only for BC but also for several other types of cancer [69]. Here, NRP2 is linked to cancer.